People · Operator
Named in public records as an officer, director or promoter · active 2007–2025 · Biotechnology, Other Technology, Software / Tech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Impulse Dynamics N.V. | — | Biotechnology | Series D+ | $417.3M | $747.7M | 2025 |
| Lyra Therapeutics, Inc. | — | Biotechnology | Series D+ | $236.6M | $791.1M | 2009 |
| Oraya Therapeutics Inc | — | Other Technology | Series B | $74.9M | $765.4M | 2009 |
| Analytics for Life, Inc. | — | Software / Tech | Series B | $65.1M | $2.6M | 2025 |
| Rox Medical Inc | — | Other Health Care | Series A | $20.5M | $112.1M | 2011 |
| EndGenitor Technologies Inc | — | Biotechnology | Seed | $2.5M | $108.8M | 2007 |
| White Pine Medical Inc. | — | Other Health Care | Seed | $1.0M | $24.8M | 2010 |
Guido Neels at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Guido Neels on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James R. Tobin | 2 | 6 |
| Konstantin Poukalov | 2 | 5 |
| Robert Langer | 1 | 36 |
| Carmichael Roberts | 1 | 15 |
| James Taylor | 1 | 12 |
| Brian Halak | 1 | 10 |
| Peter Cohn | 1 | 10 |
| Terrance McGuire | 1 | 9 |
| Edward Anderson | 1 | 8 |
| John K. Bakewell | 1 | 7 |
| Reza Zadno | 1 | 7 |
| James Goldstein | 1 | 6 |
| Carmichael S. Roberts | 1 | 6 |
| Kim Kamdar | 1 | 6 |
| Kevin Wasserstein | 1 | 5 |
| George Whitesides | 1 | 5 |
| Mark Brooks | 1 | 5 |
| James Rosen | 1 | 4 |
| Earl M. Collier, Jr. | 1 | 4 |
| John Onopchenko | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.